Sabinsa, the multi-national health science company known for providing sustainable natural, well-researched ingredients, is pleased to announce that Dr. Alphons Philips PhD, MBA has joined the company as Director—Scientific Affairs.

Dr. Philips brings extensive industry experience in drug safety, consumer product safety, cosmeceuticals, and nutraceuticals. He is an accomplished scientific affairs leader with deep expertise in clinical research, drug safety, consumer product safety, cosmetovigilance, regulatory data science, and claims substantiation across the nutraceutical and functional food industries.

“Dr. Philips’ expertise in working at the intersection of science, innovation, and compliance makes him an excellent fit for Sabinsa, and we are pleased that he has joined our team,” said Shaheen Majeed, Global CEO & Managing Director, Sami-Sabinsa Group. “His skill in translating complex data into actionable insights that drive success in the health and wellness sector will benefit the company, our customers, and the industry.”

“Sabinsa’s long history of scientific rigor and innovation based on traditional Ayurvedic knowledge initially brought the company to my attention, and Shaheen’s vision and leadership inspired me to join the team,” Dr. Philips said. “I’m pleased to bring my expertise and experience to the company.”

At Sabinsa, Dr. Philips oversees initiatives to validate the safety and efficacy of botanical ingredients through human clinical studies, supports global product development with scientifically established claims, including GRAS affirmations. With a PhD in Medical Genetics and an MBA in Healthcare Management, Dr. Philips combines scientific acumen with strategic insight, enabling data-driven decisions that meet evolving regulatory standards.